S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
BellRing Brands gets pumped on the Ozempic weight-loss trend
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
BellRing Brands gets pumped on the Ozempic weight-loss trend
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
BellRing Brands gets pumped on the Ozempic weight-loss trend
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Teva Pharma is the way to play the re-rise of generic drugs
3 reasons a squeeze could be in Paramount's coming attractions
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
BellRing Brands gets pumped on the Ozempic weight-loss trend

Tapinator Stock Price, News & Analysis (OTCMKTS:TAPM)

$0.65
-0.07 (-9.72%)
(As of 11/27/2023 ET)
Compare
Today's Range
$0.65
$0.65
50-Day Range
$0.54
$0.75
52-Week Range
$0.52
$1.18
Volume
2,000 shs
Average Volume
4,283 shs
Market Capitalization
$1.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TAPM stock logo

About Tapinator Stock (OTCMKTS:TAPM)

Tapinator, Inc. develops and publishes mobile games and applications on the iOS, Google Play, and Amazon platforms in North America and Europe. The company's library includes approximately 300 titles, such as Video Poker Classic and Crypto Trillionaire. It also provides in-app purchase and subscription services. The company was founded in 2013 and is headquartered in New York, New York.

TAPM Stock Price History

TAPM Stock News Headlines

Tapinator, Inc.: Tapinator Announces Q3 2023 Financial Results
Tapinator Announces Q3 2023 Financial Results
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Tapinator Announces Q2 2023 Financial Results
TAPM - Tapinator, Inc.
Tapinator Announces Q1 2023 Financial Results
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Tapinator Announces Q3 2022 Financial Results
Tapinator Announces Q2 2022 Financial Results
Tapinator (OTC:TAPM), Dividends
Tapinator Announces Dividend of Common Stock
See More Headlines
Receive TAPM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tapinator and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
11/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
N/A
Current Symbol
OTCMKTS:TAPM
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.54 million

Miscellaneous

Free Float
2,022,000
Market Cap
$1.77 million
Optionable
Not Optionable
Beta
2.24
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Ilya Nikolayev (Age 39)
    Executive Chairman & CEO
    Comp: $309.6k
  • Mr. Andrew P. Merkatz (Age 54)
    President, CFO & Director
    Comp: $309.6k
  • Mr. Brian Chan (Age 44)
    VP of Finance & Accounting and Secretary
    Comp: $76.71k














TAPM Stock Analysis - Frequently Asked Questions

How have TAPM shares performed in 2023?

Tapinator's stock was trading at $0.6890 at the start of the year. Since then, TAPM shares have decreased by 5.7% and is now trading at $0.65.
View the best growth stocks for 2023 here
.

Are investors shorting Tapinator?

Tapinator saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 1,000 shares, an increase of 900.0% from the October 15th total of 100 shares. Based on an average trading volume of 1,700 shares, the days-to-cover ratio is currently 0.6 days.
View Tapinator's Short Interest
.

How were Tapinator's earnings last quarter?

Tapinator, Inc. (OTCMKTS:TAPM) issued its earnings results on Monday, November, 13th. The technology company reported ($0.11) earnings per share (EPS) for the quarter. The technology company had revenue of $1.18 million for the quarter.

What other stocks do shareholders of Tapinator own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tapinator investors own include CTI BioPharma (CTIC), NVIDIA (NVDA), Patterson-UTI Energy (PTEN), SM Energy (SM), Targa Resources (TRGP), vTv Therapeutics (VTVT), Amedisys (AMED), Activision Blizzard (ATVI), CNA Financial (CNA) and Cognizant Technology Solutions (CTSH).

How do I buy shares of Tapinator?

Shares of TAPM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:TAPM) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -